Services
Radiolabelled evaluation,end to end.
Six integrated capabilities that take your product from tracer chemistry to a regulatory-ready imaging dossier.
Radiolabelling
Competence to label most chemical APIs — antibiotics, anti-inflammatories, steroids, receptor-specific drugs, proteins, vaccines, macromolecules and nano-drugs — plus formulations and cells. Pioneers of surface labelling and DPI & MDI labelling at a global level.
- APIs, biologics, proteins & vaccines
- Nano-drugs, macromolecules & cells
- Surface, DPI & MDI labelling
Pharmaco-Scintigraphy
Human and preclinical gamma scintigraphy — a non-invasive, versatile tool to scrutinise the in-vivo behaviour of your formulations.
- Human gamma scintigraphy
- Preclinical scintigraphy
- Radiochemical validation
Clinical Studies
Proof-of-concept, academic and investigator-initiated trials, and Phase 0, I & II studies with full ICH-GCP documentation.
- Proof-of-concept & academic trials
- Investigator-initiated trials
- Phase 0, I & II studies
Pharmacokinetic Studies
PK data coupled with imaging to reveal time and site of disintegration, GI transit and site-specific drug deposition.
- Time & site of disintegration
- GI transit & gastric emptying
- Site-specific deposition
Formulation Development
Preformulation, formulation design, QbD and nanotechnology-driven development tailored to your molecule.
- Preformulation & design
- QbD-driven development
- Nanotechnology formulations
Analytical & Product Evaluation
Dissolution, dermatokinetics, skin permeation and preclinical safety & efficacy evaluation.
- Dissolution & dermatokinetics
- Skin permeation studies
- Preclinical safety & efficacy
Start a Conversation
See your molecule in motion.
Partner with our scientists to design an imaging study that answers your most critical development question.